4/11/2023 0 Comments Planet simulator steam![]() ![]() ![]() We look forward to seeing the outcomes of this exciting new collaboration between the two companies. As a leading global pharmaceutical company with a purpose to battle chronic diseases, Novo Nordisk will leverage this technology platform for its target discovery activities. It further refines its selection through analysis of attention metrics, discovery trends, relevant data from Key Opinion Leaders (KOLs), and chemistry databases. The system draws from trillions of such data points to find the most promising targets and corresponding disease indications. Insilico's PandaOmics is an #AI-driven target discovery platform that applies deep learning models to identify therapeutic targets associated with a given disease. The pharmaceutical company will then conduct experimental validation of the nominated targets. Novo Nordisk is utilizing Insilico’s target discovery engine, PandaOmics, in conjunction with its own drug research and development expertise, to yield new target hypotheses of interest to Novo Nordisk. The aim is to discover new therapeutic targets for liver fibrosis. I am excited to share that Insilico Medicine and Novo Nordisk have signed a collaboration agreement. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |